Survival curves after ARI0002h infusion. (A-B) PFS and OS of the cohort. (C-D) PFS and OS based on the absence (blue, n = 30) or presence (red, n = 33) of EMD disease. (E-F) PFS and OS based on the absence (blue, n = 30) or presence of PS (pink, n = 21) or EMD (brown, n = 12) plasmacytomas at inclusion.